Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW)))) (the "Company" or "Nexalin") today announced the pricing of a p...

- SEC Filing We are offering on a reasonable best effort basis up to $7,000,000 of our common stock, $0.001 par value per shar...

Study demonstrates strong statistical separation between patients receiving Nexalin's DIFS® technology in combination with ...

https://www.youtube.com/watch?v=6nIaEXjW_uI

- SEC Filing

Nexalin Technology, Inc. (NASDAQ: NXL) shares surged on Friday afternoon following the announcement of a new patent awarded by ...